Navigation Links
Researchers developing antiviral drug to combat contagious norovirus
Date:3/25/2013

MANHATTAN -- A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year, according to the Centers for Disease Control and Prevention.

Kyeong-Ok Chang, associate professor of diagnostic medicine and pathobiology, is leading researchers as they develop an antiviral drug for market use. The team -- supported by a five-year $5.1 million National Institutes of Health grant -- has identified and is further testing several protease inhibitors with potential for preventing and treating norovirus infection.

Norovirus is the most common form of viral gastroenteritis. It is often called the stomach bug because it causes vomiting and diarrhea for several days. A new Sydney strain of norovirus emerged last year and the Centers for Disease Control and Prevention recently reported that this new strain is now behind 60 percent of norovirus outbreaks.

"You can control infectious diseases by vaccinations, antibiotics for bacterial agents or antiviral drugs for viral agents," said Chang, who has devoted his career to studying noroviruses and rotaviruses, another form of gastroenteritis. "We know that antibiotics and antiviral drugs are a tremendous help to human health. Our goal is to help the patient."

There is currently no vaccine and no antiviral drug to combat norovirus, Chang said. While several organizations are researching vaccine development, Chang's research team is one of the leading groups studying antiviral drugs as a way to treat norovirus.

"The main focus of our research is antiviral drugs because public awareness to norovirus outbreaks is increasing and so is the demand for ways to control norovirus infection," Chang said. "Our team is one of a few groups that have pioneered antiviral drug development in the norovirus field."

Research collaborators at Kansas State University include Duy Hua, a university distinguished professor of chemistry, and Yunjeong Kim, research assistant professor of diagnostic medicine and pathobiology. Other collaborators include William Groutas, a distinguished professor of chemistry at Wichita State University; and Linda Saif, a distinguished professor in the department of veterinary preventive medicine's food animal health research program at Ohio State University.

Each scientist on the team is contributing expertise to the norovirus drug development project. Hua and Groutas are medicinal chemists and are synthesizing compounds specifically designed to bind a virus protein that is essential for virus survival. Chang and Kim are virologists and are testing those compounds in enzyme assays and cell-based assays to determine their effects on the virus. Saif is a virologist and also tests compounds.

"Unlike most bacteria, viruses can only grow in cells," Chang said. "One of the most important ways to tell if a compound is effective against a virus is to test that compound in cell culture to see if it can inhibit the growth of the virus. However, human norovirus does not grow in cells, which has been a great impediment to the development of vaccines and antiviral drugs. That is why we established cell-based assays ourselves. That's our novelty. That's why we initiated this program from Kansas State University and then we looked for collaborators."

In the past few years, the researchers have studied more than 600 compounds and found several compounds with the best potential for drug development. The researchers also are focusing on protease inhibitors, which could prevent viruses from replicating in cells. Other protease inhibitors exist in the market for treating HIV or hepatitis C virus infections.

"Viral proteases are a very good target for antiviral drug development because a virus cannot replicate without its protease," Chang said. "That's why our research has focused on norovirus proteases and protease inhibitors. We know that certain basic structures on our protease inhibitors are effective at inhibiting norovirus, so we continue to generate more compound derivatives based on these basic structures. A compound needs to be effective in enzyme assay and cell-based assay. The compounds also need to have very good pharmacokinetics. We are confident that our compounds can go further than the laboratory."

The scientists also are performing basic virology studies to advance their work further. They are studying how the compounds bind to the virus protease and inhibit protease function using X-ray crystallography and other enzymology tools. In addition, the scientists are investigating other potential targets for developing anti-norovirus drugs, such as host factors to diversify their approaches to norovirus control.

The researchers have filed a patent application for their research. They have published more than 20 papers in the last four years, including articles in the Journal of Virology, the Journal of Medicinal Chemistry, PLOS Pathogens and several other journals.
'/>"/>

Contact: Kyeong-Ok Chang
kchang@k-state.edu
785-532-3849
Kansas State University
Source:Eurekalert

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Researchers Map Brain Regions Linked to Intelligence
9. Researchers ID Genes That May Determine Mental Illness
10. Researchers Develop Blood Test for Depression
11. University of Cincinnati researchers win $3.7M grant from US Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology: